- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00226031
Optimal Management of Women With Wrist Fractures
Optimal Management of Older Women With Distal Forearm Fractures
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Numerous studies have demonstrated that women with wrist fractures have lower bone mineral density. Despite new guidelines for the care of such women, research has shown that they are not generally evaluated for osteoporosis. This care gap exists although it is known that wrist fractures are an important marker for subsequent fractures, such as a hip fracture, which represents a significant socio-economic burden to society.
Comparison: Cluster randomized trial of women and their physicians, both of whom receive educational material and reminder on post fracture osteoporosis evaluation. Comparison is to women and their physicians who receive standard post fracture information. Family practices are randomized to intervention or non-intervention group.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Ontario
-
Kingston, Ontario, Kanada, K7L 3N6
- Queen's University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Postmenopausal women with low trauma distal radius fracture (confirmed by x-ray).
- Can be taking Didrocal (etidronate), Miacalcin (calcitonin),or hormone replacement therapy .
Exclusion Criteria:
- Women with fractures of the elbow, mid radius, scaphoid, or injury to wrists (without actual fracture).
- Significant cognitive impairment (which would preclude them from filling out simple questionnaires).
- Women already taking osteoporosis therapy, ie. either Fosamax (alendronate), Actonel (risedronate), or the selective estrogen receptor modulator, Evista (raloxifene).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: 1
Usual care.
|
Family practices were randomly assigned to intervention or usual care.
The intervention was a mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the GP and a letter and educational package for the women.
|
Experimentell: 2
Mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the family physician and a letter and educational package for the women.
|
Family practices were randomly assigned to intervention or usual care.
The intervention was a mailed reminder with a summary of osteoporosis screening and treatment guidelines sent to the GP and a letter and educational package for the women.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Proportion of women who are prescribed anti-osteoporosis therapy within 6 months of sustaining a forearm fracture.
Tidsram: 6 months
|
6 months
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Proportion of women in whom a bone density scan is ordered and the proportion of women who receive counseling advice about osteoporosis from their family physicians.
Tidsram: 6 months
|
6 months
|
Women's knowledge about osteoporosis and fractures (Osteoporosis Knowledge Questionnaire).
Tidsram: 6 months
|
6 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Ann B Cranney, MD, Queen's University
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- KTS-62358
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Educational Material and Reminder
-
St. Jude Children's Research HospitalRekryteringMolekylär och klinisk riskriktad terapi för spädbarn och småbarn med nydiagnostiserat medulloblastomMedulloblastomFörenta staterna